CJC-1295 (DAC)

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone releasing hormone (GHRH) analogue studied for its potential role in sustained growth hormone secretion and IGF-1 elevation. The DAC modification extends its half-life significantly compared to standard CJC-1295, making it a subject of interest in research exploring prolonged growth hormone releasing activity.

Explore the Apex Research Series →

For research use only. Not for human consumption.

$95.00

Scroll to Top